133 related articles for article (PubMed ID: 12311059)
1. [Evolution of plasmatic apolipoprotein B, cholesterol and triglyceride levels in fourty-five long-term combined oral contraceptive users (author's transl)].
Merger C; Verine A; Boyer J
Contracept Fertil Sex (Paris); 1981 Oct; 9(10):615-20. PubMed ID: 12311059
[TBL] [Abstract][Full Text] [Related]
2. The influence of high- and low-dose hormonal contraceptives on HDL and total cholesterol levels.
Pretnar Darovec A; Novacan Hudnik S
Acta Reprod Turc; 1987; 8(3-4):37-42. PubMed ID: 12316487
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
4. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
5. Oestroprogestogen interference on some haematochemical parameters: glycaemia, lipid metabolism and hepatic functionality (author's transl).
Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
Patol Clin Ostet Ginecol; 1981; 9(1):7-17. PubMed ID: 12278646
[TBL] [Abstract][Full Text] [Related]
6. [Hyperlipidemia aggravated or induced by combined oral contraceptives: preliminary results of a decision-making scheme for the prevention of cardiovascular episodes].
Narboni G; Seklaoui T; Gillet JY; Colette C; Grandmottet P
J Med Besancon; 1978; 14(3-4):107-10. PubMed ID: 12338582
[TBL] [Abstract][Full Text] [Related]
7. [Oral contraceptives, risk factor of myocardial infarction related to blood lipids (author's transl)].
Limouzin-lamothe MA; Serog P
Contracept Fertil Sex (Paris); 1980 Apr; 8(4):295-303. PubMed ID: 12278330
[TBL] [Abstract][Full Text] [Related]
8. Effects of the triphasic oral contraceptive on lipid and lipoprotein metabolism.
Kirumbi LW; Maina FW; Sekadde Kigondu CB; Mati JK
J Obstet Gynaecol East Cent Africa; 1991; 9(1):23-9. PubMed ID: 12316812
[TBL] [Abstract][Full Text] [Related]
9. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
10. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and safety of a new combined oral contraceptive containing 75 micrograms gestodene and 30 micrograms ethinyl estradiol in Mexican women].
Martinez M; Perez Palacios G; Garza Flores J; Bassol S; Recio R
Invest Med Int; 1990; 17(1):3-9. PubMed ID: 12283863
[TBL] [Abstract][Full Text] [Related]
12. Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
Tangney CC; Driskell JA
Nutr Rep Int; 1977 Jul; 16(1):139-46. PubMed ID: 12335121
[TBL] [Abstract][Full Text] [Related]
13. The effect of two low-dose oral contraceptives and non-hormonal contraception on serum lipids and high-density lipoprotein cholesterol.
Saure A; Heikkinen JE; Ylostalo P
Contracept Deliv Syst; 1984 Apr; 5(2):83-90. PubMed ID: 12266199
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
[TBL] [Abstract][Full Text] [Related]
15. Effect of low dosage contraceptive pills on serum pseudocholine esterase level.
Nagui AR; Shaarawy M; El Khodary M; Shalaby M; Mikaty N
J Egypt Soc Obstet Gynecol; 1976; 2(3):41-4. PubMed ID: 12309833
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
17. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
18. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
[TBL] [Abstract][Full Text] [Related]
19. Effects of a very low-estrogen oral contraceptive on clotting factors, carbohydrate metabolism and plasma lipids and lipoproteins.
Thiery M; Vermeulen A; Baele G; Deslypere JP
Med Sci Res; 1987 Oct 16-31; 15(20):1231-2. PubMed ID: 12282907
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Ishak R; Loh Chooi Khim
Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
